Predicting risk of malignancy in adnexal masses

Obstetrics and Gynecology

Volumn 115, Issue 4, 2010, Pages 687-694

  Van Nagell Jr , John R ^a   McDonald, John M ^a   Doran, Stacey ^a   Desimone, Christopher P ^a   Ueland, Fred R ^a   Depriest, Paul D ^a   Ware, Rachel A ^a   Saunders, Brook A ^a   Pavlik, Edward J ^a   Goodrich, Scott ^a   Kryscio, Richard J ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADNEXA DISEASE; ADULT; ARTICLE; BENIGN TUMOR; CANCER RISK; CANCER STAGING; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY CANCER; OVARY CYST; OVARY TUMOR; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME;

ADNEXAL DISEASES; AGE FACTORS; CA-125 ANTIGEN; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; POSTMENOPAUSE; PREMENOPAUSE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 77949896473     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181d44053     Document Type: Article

References (17)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M. Cancer statistics 2009. CA Cancer J Clin 2009;59:225-249
2. Goff BA, Mandel LS, Melancon CH, Muntz HG. Frequency of symptoms of ovarian cancer in women presenting to primary care clinics. JAMA 2004;291:2705-2712
3. Smith LH, Morris CR, Yasmeen S, Parikh-Patel A, Cress RD, Romano PS. Ovarian cancer: can we make the clinical diagnosis earlier? Cancer 2005;104:1398-1407
4. Goff BA, Mandel L, Drescher CW, Urban N, Gough S, Schurman KM, et al. Development of an ovarian cancer symptom index. Cancer 2007;109:221-227
5. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-1259
6. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Aghajanian C, Barakat RR, Chi DS. The effect of maximal surgical cytore-duction on sensitivity to platinum-taxane chemotherapy and subsequent survival in patients with advanced ovarian cancer. Gynecol Oncol 2008;108:276-281
7. Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, et al. The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. Gynecol Oncol 2006;103:1083-1090
8. van Nagell JR, DePriest PD, Ueland FR, DeSimone CP, Cooper AL, McDonald AM, et al. Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened. Cancer 2007;109:1887-1896
9. Breiman L, Friedman J, Olshen R, Stone C. Classification and regression trees. New York (NY): Wadsworth; 1984.
10. Roman LD. Small cystic pelvic masses in older women: is surgical removal necessary? Gynecol Oncol 1998;69:1-2.
11. Modesitt SC, Pavlik EJ, Ueland FR, DePriest PD, van Nagell JR Jr. Risk of malignancy in unilocular ovarian cystic tumors less than 10 cm in diameter: a long-term follow-up study. Obstet Gynecol 2003;102:594-599
12. Im S, Gordon A, Buttin B, Leath CA III, Gostout BS, Shah C, et al. Validation of referral guidelines for women with pelvic masses. Obstet Gynecol 2005;105:34-41
13. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer. ACOG Committee Opinion No. 280. American College of Obstetricians and Gynecologists. Obstet Gynecol 2002;100:1413-1416
14. Dearking AC, Aletti G, McGree M, Weaver AL, Sommer-field M, Cliby WA. How relevant are ACOG and SGO guidelines for referral of an adnexal mass. Obstet Gynecol 2007;110:841-848
15. Le T, Adolph A, Krepart G, Lotocki R, Heywood MS. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma. Gynecol Oncol 1992;47:223-227
16. Suh-Burgman E. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecol Oncol 2006;103:841-847
17. Hereditary breast and ovarian cancer syndrome. ACOG Committee on Practice Bulletins. Gynecol Oncol 2009; 113:6-11.